|
|
|
Volumn 31, Issue 6, 2006, Pages 541-564
|
|
Drugs under development for the treatment of breast cancer
a
a
PROUS SCIENCE
(Spain)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 PHENYLACETAMIDO 2,6 PIPERIDINEDIONE;
ACTIVIN;
ADVEXIN;
ALPHA2B INTERFERON;
AMONAFIDE;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTON AS2-1;
ARSENIC TRIOXIDE;
ARZOXIFENE;
ATAMESTANE;
BEVACIZUMAB;
BEXAROTENE;
BORTEZOMIB;
CETUXIMAB;
CISPLATIN;
COMBRETASTATIN A4 PHOSPHATE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOCETAXEL;
DOXORUBICIN;
ERLOTINIB;
FLUOROURACIL;
GONADORELIN[6 DEXTRO LYSINE] DOXORUBICIN;
IRINOTECAN;
METHOTREXATE;
NANOPARTICLE;
PACLITAXEL;
SORAFENIB;
TOREMIFENE;
UNINDEXED DRUG;
VASCULOTROPIN INHIBITOR;
ACUTE GRANULOCYTIC LEUKEMIA;
ARTERY OCCLUSION;
BREAST CANCER;
BREAST METASTASIS;
CANCER ADJUVANT THERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CLINICAL TRIAL;
COLORECTAL CANCER;
DRUG ACTIVITY;
DRUG APPROVAL;
DRUG BIOAVAILABILITY;
DRUG DISTRIBUTION;
DRUG FORMULATION;
DRUG INHIBITION;
DRUG MARKETING;
DRUG PENETRATION;
DRUG POTENTIATION;
DRUG STRUCTURE;
ESOPHAGUS CANCER;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL STROMAL TUMOR;
GLIOMA;
HEAD AND NECK CANCER;
HUMAN;
KIDNEY CANCER;
KIDNEY CARCINOMA;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
MELANOMA;
MULTIPLE MYELOMA;
NONHUMAN;
OSTEOPOROSIS;
OVARY CANCER;
PERITONEUM CANCER;
PROMYELOCYTIC LEUKEMIA;
PROSTATE CANCER;
PSORIASIS;
REVIEW;
SQUAMOUS CELL CARCINOMA;
T CELL LYMPHOMA;
UNSPECIFIED SIDE EFFECT;
|
|
EID: 33748806029
PISSN: 03778282
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (7)
|
|
References (0)
|
